The project will develop a commercially viable ENforce Bionic Foot bionic prosthesis, which will be significantly superior to the products available on the market in terms of performance and business model. The Enforce Bionic Foot will provide a person after amputation with the ability to move as close to natural as possible. It will allow you to return to normal, everyday activities, minimising the risk of additional skeletal problems over time, which in traditional dentures result from asymmetrical load distribution in healthy parts of the locomotor system.
CARLSON INVESTMENTS SE under the agreement concluded with Carlson Ventures International Limited (CVI), being the sole investor of Carlson ASI Evig Alfa Sp. z o.o. Sp. k., is entitled to receive up to 30% of the profit on this investment as realised by CVI through Carlson ASI Evig Alfa Sp. z o.o. Sp. k.